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Abstract: Background: Chronic obstructive pulmonary disease (COPD) is characterized by
irreversible airflow obstruction and inflammation. Natural products, such as monoterpenes,
displayed anti-inflammatory and anti-oxidant activities and can be used as a source of new
compounds to COPD treatment. Our aim was to evaluate, in an elastase-induced pulmonary
emphysema in mice, the effects of and underlying mechanisms of three related natural monoterpenes
(p-cymene, carvacrol and thymol) isolated from essential oil from leaves Lippia sidoides Cham.
(Verbenaceae). Methods: Mices received porcine pancreatic elastase (PPE) and were treated with
p-cymene, carvacrol, thymol or vehicle 30 min later and again on 7th, 14th and 28th days. Lung
inflammatory profile and histological sections were evaluated. Results: In the elastase-instilled
animals, the tested monoterpenes reduced alveolar enlargement, macrophages and the levels of
IL-1β, IL-6, IL-8 and IL-17 in bronchoalveolar lavage fluid (BALF), and collagen fibers, MMP-9
and p-65-NF-κB-positive cells in lung parenchyma (p < 0.05). All treatments attenuated levels
of 8-iso-PGF2α but only thymol was able to reduced exhaled nitric oxide (p < 0.05). Conclusion:
Monoterpenes p-cymene, carvacrol and thymol reduced lung emphysema and inflammation in mice.
No significant differences among the three monoterpenes treatments were found, suggesting that the
presence of hydroxyl group in the molecular structure of thymol and carvacrol do not play a central
role in the anti-inflammatory effects.
Keywords: COPD; elastase-induced emphysema; monoterpenes; p-cymene; carvacrol; thymol;
lung inflammation
1. Introduction
Pulmonary emphysema is a main constituent of chronic obstructive pulmonary disease (COPD),
which is associated to high morbidity and mortality in worldwide but commonly preventable and
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treatable. It is characterized by alveolar destruction and abnormal permanent enlargement of the alveoli
which leads to severe airflow limitation [1]. Inflammatory cells such as neutrophils, macrophages
and lymphocytes are activated and release several pro-inflammatory mediators such as interleukin
IL1-β, IL-6 and IL-8 [2–6]. Recently, new interleukins had their role recognized which are involved in a
wide variety of inflammatory response such as IL-15, IL-18, IL-21, IL-22, IL-23, IL-27, and IL-33 [7].
Commonly, IL-17, which has been become attention since it is produced in a particularly subset of
T Helper cells called Th17, is involved in sustaining the inflammation amplifying the inflammatory
responses [7]. Moreover, the cyclo-oxygenases that control the production of prostaglandins and
thromboxanes [8] are also involved in the modulation of lung inflammation and a flavone chrysin
suppressed inflammatory response by the interaction with COX-2 binding site [9]. In addition, the
translocation of nuclear transcription factor NF-κB to the nucleus up-regulates the transcription of
several cytokines and pro-inflammatory mediators [10–12]. The main cause of COPD is the inhalation
of cigarette smoke [13] which causes an increase in oxidative stress that plays a central role in this
disease because it is both generated due to increased reactive oxygen and nitrogen species induced
by smoke as well as produced by activated inflammatory cells [13,14]. Isoprostanes are generated
at the end of the membrane lipid peroxidation cascade and has been used as an indirect marker of
oxidative stress [15–18]. Moreover, exhaled nitric oxide, which is mainly produced by inducible nitric
oxide enzyme (iNOS) in inflammatory situations, could also have been used as an inflammatory and
oxidative stress marker, particularly if it is associated to other parameters [19,20]. Other mechanism
involved in emphysema is the imbalance between protease and antiprotease that is responsible
for the lung destruction. Neutrophil elastase, metalloproteases and cathepsins are responsible for
the degradation of the proteins in alveolar wall extracellular matrix, such as collagen and elastin
fibers, thereby causing the lung destruction. Oxidative stress is also involved in the inhibition of
the antiprotease activities. The destruction and repair process in response to the presence of chronic
inflammation and oxidative stress culminate in a remodeling process which is characterized by an
increase in collagen deposition and broken of elastic fibers compromising the mechanical properties of
the lung [21,22].
Medicinal plants and their constituents have been widely used to treat several diseases since
ancient times and many natural products have been related to effectively counteract lung inflammation
in acute and chronic models of lung disease [23,24]. In this regard, drugs that present anti-inflammatory
properties have been extensively studied since unwanted side effects are associated to the traditional
treatments for inflammation [23,24]. p-Cymene, carvacrol and thymol are structurally related aromatic
monoterpenes obtained from essential oils from different plant species [25]. Thymol and carvacrol are
phenolic compounds belonging to a class of natural antioxidants due to the presence of one hydroxyl
group linked to aromatic ring and the possibility of stabilizing free radicals formation [26], which
is associated to preventing lipid peroxidation [27]. A related monoterpene derivative, p-cymene,
displayed a similar structure of thymol and carvacrol, but the hydroxyl group is absent in the aromatic
ring. Considering that these compounds displayed different biological activities, including antitumoral,
antibacterial, antifungal, anti-inflammatory, and antioxidant activities [28–30], the aim of the present
study was to investigate the effects and underlying mechanisms of natural monoterpenes p-cymene,
carvacrol and thymol, isolated from essential oil from leaves Lippia sidoides (Verbenaceae) in an
elastase-induced pulmonary emphysema model in mice.
2. Results
2.1. Chemical Analysis of Isolated Monoterpenes from Essential Oil from Leaves of L. sidoides
The 13C-NMR spectra of three isolated monoterpenes from essential oil from leaves of L. sidoides
showed peaks of sp2 carbons at range δ 112–154 assigned to aromatic ring (C-1 to C-6) and methyl
group linked to aromatic ring at δ 15–21 (C-10). Additionally, the presence of two equivalent methyl
groups at δ 22–24 and one methyne carbon at δ 26–37 indicated the presence of one isopropyl group.
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The comparison of obtained spectral data with those reported in the literature [31], associated to
LREIMS analysis [32], allowed the identification of the monoterpenes p-cymene, carvacrol and thymol,
as shown in Figure 1.
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Figure 1. Structure of monoterpenes p-cymene, carvacrol and thymol.
2.2. Monoterpenes Reduced BALF Lung Inflammation in PPE-Induced Emphysema in Mice
Figure 2 shows the number of total cells as well as the number of macrophages, neutrophils,
lymphocytes, and eosinophils recovered in BALF. The PPE instillation increased inflammatory cells
in BALF, particularly macrophages, compared to SAL + VE group (p < 0.01 for both comparisons).
The treatment with monoterpenes p-cymene, carvacrol and thymol reduced the nu ber of total cells
and macrophages (PPE + CA an PPE + pC, p < 0.01 and PPE + TM, p < 0.05) in BALF compared
to value obtained in PPE + VE group. No differences were detected in the number of neutrophils,
lymphocytes and eosinophils among the experimental groups.
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Figure 2. Eff cts of monoterpenes p-cymene, carvacrol and ymol on lu g inflammation. Data are
presented as mean ± standa d error (SE) (n = 7 to 8 mice/group) of number of cells reco red in
bronchoalveolar lavage fluid collected at the 28th day of the experimental pro ocol. SAL + VE: control
group with vehicle tre tment; PPE + VE: porcine panc ic elastase instillation and vehicle treatment;
PPE + TM: porcine pancrea ic elastase instillatio and thymol treatment; PPE + CV: porcine pancreatic
elastase instillation and carvacrol treatment; PPE + pC: porcine pancreatic elastase instillation and
p-cymene treatment. * p < 0.01 and # p < 0.05.
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2.3. Monoterpenes Reduced Cytokines in BALF in PPE-Induced Emphysema in Mice
To investigate the role of tested monoterpenes in modulating the secretion of cytokines in BALF,
the levels of IL-6 (Figure 3A); KC, which is homologous to IL-8 in humans (Figure 3B); IL-1β (Figure 3C);
and IL-17 (Figure 3D) were measured using ELISA. The PPE + VE group showed higher levels of IL-6
(p < 0.05), KC (p < 0.05), IL-1β (p < 0.001) and IL-17 (p < 0.01) compared to SAL + VE group. Moreover,
the treatment with monoterpenes p-cymene, carvacrol and thymol reduced the levels of these cytokines
in a similar mode to those observed in SAL + VE group (IL-6: p < 0.01; KC: p < 0.05; IL-1β and IL-17:
p < 0.001 for the three treatments). Notwithstanding, the levels of IL-17 in thymol treated animals were
also reduced in comparison to control animals (p < 0.05).
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2.4. Monoterpenes Prevented Alveolar Septa Destruction Reduced the Collagen Fibers Deposition Probably by
Controlling MMP-9/TIMP-1 in PPE-Induced Emphysema Model
The evaluation of lung emphysema and collagen deposition as well as the MMP-9/TIMP-1 balance
is shown in Figure 4. The mean linear intercept (Lm) was used as indicator of alveolar destruction in
mice. Mean Linear Intercepts (Lm) increased in PPE + VE group compared to the animals that received
saline and vehicle treatment (SAL + VE) (p < 0.001) (Figure 4A). The tested monoterpenes attenuated
the emphysema, as shown by the lower values of LM observed in PPE + TM, PPE + CV and PPE + pC
groups (p < 0.01) compared with ELA + VE group. However, the treated animals showed high values
of LM when compared to SAL + VE group (p < 0.05).
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Figure 4. Effects of monoterpenes thymol, carvacrol and p-cymene on alveolar septa. Data are
presented as mean ± standard error (SE) (n = 5 mice/group) of: mean linear intercepts (Lm) (A);
volume proportion of collagen fibers (B); and the number of positive cells to MMP-9 (C); and TIMP-1
(D) in lung of mice in the 28th day of the protocol. The photomicrographs represent the lung tissue of
one animal from control (E,L,Q,V), PPE treated with vehicle (F,M,R,W) and PPE treated with thymol
(G,N,S,X), carvacrol (H,O,T,Y) or p-cymene group (K,P,U,Z) stained with HE (first line), picro-sirius
to detect collagen fibers (second line), by immunohistochemistry to MMP-9 and TIMP-1 (third and
fourth line respectively). Arrows indicate lung emphysema, collagen deposition and positive cells.
SAL + VE: control group with vehicle treatment; PPE + VE: porcine pancreatic elastase instillation and
vehicle treatment; PPE + TM: porcine pancreatic elastase instillation and thymol treatment; PPE + CV:
porcine pancreatic elastase instillation and carvacrol treatment; PPE + pC: porcine pancreatic elastase
instillation and p-cymene treatment. * p < 0.01, ** p < 0.001 and # p < 0.05.
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Due to degradation of the fibers to be usually followed by a turnover of collagen, collagen content
(Figure 4B) in alveolar septa of mice was measured. The obtained results indicated an increase of
proportion of collagen fibers in alveolar septa of ELA + VE animals compared with the SAL + VE
group (p < 0.01) and the treatments reduced this response (p < 0.05). Since balance between MMPs
and TIMPs is involved in the control of the degradation and turnover of the fibers, was quantified
the expression of MMP-9 (Figure 4C) and TIMP-1 (Figure 4D) in cells presented in alveolar septa.
The obtained results showed an increase of MMP-9 (p < 0.01) and TIMP-1 (p < 0.05) positive cells in
alveolar septa from ELA + VE group compared with the control group (SAL + VE). Interestingly, the
positive cells to MMP-9 were reduced in lung of the animals that received elastase and were treated
with p-cymene, carvacrol and thymol (p < 0.05) compared with ELA + VE group. However, the number
of positive cells to TIMP-1 in alveolar septa of animals that received elastase and treated with tested
monoterpenes was similar to those observed in ELA + VE group.
The photomicrographs represent the lung tissue of one animal from control, PPE treated with
vehicle and PPE treated with thymol, carvacrol or p-cymene groups stained with HE (E to K), with
picro-sirius to collagen detection (L to P), as well as immunostained to detect MMP-9 (Q to U) and
TIMP-1 (V to Z) positive cells. The PPE group showed large alveolar spaces with intense collagen
deposition and increased positive cells to MMP-9 and TIMP-1 (F, M, R and W) compared to control
and to treated groups.
2.5. The Monoterpenes Probably Acts in Reduction of Emphysema and Lung Inflammation in Mice by Reducing
Oxidative Stress and in NF-κB Expression in Lung
In order to understand some possible mechanisms involved in the effects of monoterpenes
p-cymene, carvacrol and thymol in lung emphysema, the expression of the subunit p-65-NF-κB in
lung parenchyma by immunohistochemistry was evaluated (Figure 5). This subunit is necessary to
activate the NF-κB gene [10], which indirect reflects the activation of this pathway. The obtained results
indicated that PPE induced an increase in the number of NF-κB positive cells compared with SAL + VE
group (p < 0.01) which was attenuated by monoterpene treatment (p < 0.01 for carvacrol and p-cymene
and p < 0.05 for thymol) (Figure 5A). Other possible mechanism involved in the action of tested
monoterpenes is associated to reduction of oxidative stress, since these compounds are anti-oxidants.
In this context, was evaluated the volume proportion of isoprostane expression (8-iso-PGF2α) in lung
tissue. In this aspect, was observed an increase in the expression of isoprostane in PPE + VE animals
compared with SAL + VE group (p < 0.001) (Figure 5B) which is also attenuated by monoterpenes
treatments (thymol/p-cymene p < 0.01 and carvacrol p < 0.05). Carvacrol-treated animals also presented
high levels of isoprostane compared to thymol (p < 0.05). The detected nitric oxide in exhaled air (ENO)
is a useful marker of both pulmonary inflammation and oxidative stress. Animals that received PPE
instillation and treated with vehicle (PPE + VE) showed high levels of ENO compared with SAL + VE
group (P < 0.05) (Figure 5C). In addition, only thymol treated animals showed lower valued of ENO
compared to ELA + VE (p < 0.05).
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Figure 5. Effects of monoterpenes thymol, carvacrol and p-cymene in the NF-κB expression in
alveolar septa and oxidative stress pathway. Data are presented as mean ± standard error (SE)
(n = 5 to 7 mice/group) of the number of positive cells to NF-κB (A) detected in alveolar septa, the
volume proportion of 8-iso-PGF-2α expression (B) detected in alveolar septa and exhaled nitric oxide
detected in the exhaled air (C) from mice in the day 28 of the protocol. Panels D to H represent tissue
stained to detect NF-κB and panels I to M to detect isoprostane by immunohistochemistry. Arrows
represent positive cells in lung tissue. SAL + VE: control group with vehicle treatment; PPE + VE:
porcine pancreatic elastase instillation and vehicle treatment; PPE + TM: porcine pancreatic elastase
instillation and thymol treatment; PPE + CV: porcine pancreatic elastase instillation and carvacrol
treatment; PPE + pC: porcine pancreatic elastase instillation and p-cymene treatment. * p < 0.01,
** p < 0.001 and # p < 0.05.
The photomicrographs represent the lung tissue of one control animal, PPE treated with vehicle
and PPE treated with thymol, carvacrol or p-cymene group stained with immunohistochemistry to
detect positive cells to NF-κB (D to H) and 8-isoprostane (I to M).
3. Discussion
PPE instillation in mice is a useful model to reproduce quickly several features of human
emphysema [33,34] and PPE instillation increased macrophages as well as IL-6, KC, IL-1β and IL-17
levels in BALF. PPE also induced lung destruction, collagen deposition and an imbalance between
MMP-9 and TIMP-1 expression. These changes were associated to high levels of nitric oxide detected
in exhaled air and increase the isoprostane expression in lung tissue. Finally, the number of positive
cells to NF-κB in lung was increased in PPE-instilled animals. Most of these features observed in this
model have been previously reported in the literature [35,36] and some of these alterations have been
already present 60 min after the PPE instillation [37].
In the world, 65 million people have moderate to severe COPD [38] and although there is a range
of available drugs, the efficacy of many existing anti-inflammatory drugs have been disappointing in
COPD patients. In this context, compounds derived from plants must be investigated as an additional
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potential therapeutic approach, particularly those which present anti-oxidant effects, since oxidative
stress is one of the primary mechanisms involved in the development of COPD [39].
The present study shows that the monoterpenes p-cymene, carvacrol and thymol, extracted from
essential oil from leaves of L. sidoides, reduced the inflammatory changes and the alveolar enlargement
observed in a murine emphysema model. These changes could be associated, at least in part, with
reduced NF-κB expression and cytokine release as well as the control of oxidative stress. Moreover,
these treatments also attenuated the MMP-9 expression in cells present in alveolar septa.
Increased number of inflammatory cells, such as neutrophil and macrophage, are presented in
the lung and in BALF from COPD patients [2]. In animals models, the activation and increase in
the number of neutrophils are observed particularly in the early phase. Other authors have found
increased neutrophils only four days after elastase instillation, whereas 21 or 28, the mainly was
characterized by the presence of macrophages in BALF [40,41]. The treatment with monoterpenes was
able to reduce the number of macrophage recovered in the BALF in the present study.
Macrophage is an important cell involved in emphysema physiopathology and is able to release
several inflammatory mediators involved in the destruction of the alveolar parenchyma [42–44]. Tumor
necrose factor (TNF) –α, interferon-γ and various classes of interleukins as the IL-1β, IL-6, IL-8, IL-10,
IL-17, IL-18, IL-32 and others are involved in the progression of emphysema [4,45]. The monoterpenes
reduced both levels of IL-6, and KC which is homologous with IL-8 in humans [46]. Increase levels
of IL-6 and IL-8 were detected during COPD exacerbation in serum and in induces sputum and in
BALF [47,48].
The IL-17, and its receptor IL17R, was first identified in CD4 + T cells. However, the IL-17,
a pro-inflammatory cytokine, has become of a great interest because it is produced by a specifically cell
subtype called Th17. The IL-17 pathway is involved in the host defense and plays a critical role in both
acute and chronic inflammatory diseases. IL-17 is involved in either benefic or malefic effects for health
protective because it can exacerbate immune responses and is produced highly by patients with chronic
inflammatory diseases [49,50]. Moreover, some authors demonstrated that IL-17 is involved mainly in
sustaining inflammatory responses rather than to initiate an inflammatory reaction [51]. In lung, the
blockade of IL-17R reduced airway inflammation and hyperreactivity in an asthma model [52].
The expression of IL-17 has previously been shown in COPD patients and it seems that IL-17A
induces the secretion of neutrophils-recruiting chemokines such as the expression of IL-6 in bronchial
epithelial cells and fibroblasts [6,40,53] as well as increase IL-8 production [54]. More importantly, the
levels of IL-17 were inversely correlated with lung function [55] in patients with COPD. Monoterpenes
p-cymene, carvacrol and thymol reduced IL-17 levels in BALF. Kurimoto et al. [40] have shown that
IL-17 is necessary to elastase-induce emphysema in experimental models. Interestingly, we also found
a reduction in the levels of IL-1β induced by monoterpenes treatment. The IL1-β can be released by
monocytes, macrophages and fibroblast and is increased in the peripheral blood, in sputum and in
BALF from COPD patients [4]. In an experimental model, Lappalainen et al. [3] demonstrated that
genetically modified mice, which expressed human IL-1β, developed an intense inflammatory process
characterized by increased neutrophils and macrophages as well as emphysema.
Other authors showed the effects of other monoterpenes in the reduction of inflammation
in experimental lung diseases [56–60]. In this regard, Boskabady and Gholami [57] showed that
Zataria multiflora and it main constituent carvacrol reduced the inflammatory cells recovered from
BALF and the levels of IL-8 in an emphysema model. Zhou et al. [60] using an asthma model showed
that thymol isolated from L. sidoides reduced inflammatory cells in airways and the levels of Th2
cytokines in BALF. Sun et al. [58] observed that the monoterpene paeoniflorin reduced inflammation
and cytokines after OVA exposure. Recently, Zhao et al. [59] showed that 1,8-cineol reduced TNF-α
and IL-1β levels in BALF in an acute lung injury model. Finally, Xie et al. [56] showed that p-cymene
reduced inflammatory cells and cytokines in ALI model. However, no data were found comparing the
biological effects of structural related monoterpenes in emphysema.
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The imbalance between proteases and anti-proteases can contribute to the lung destruction
in emphysema. The obtained results showed that monoterpenes thymol, carvacrol and p-cymene
attenuate alveolar destruction in this model. Moreover, these treatments reduced collagen deposition
in alveolar septa, suggesting that the reduction in lung destruction and inflammation could avoid
the fibers remodeling. It is well known that MMP-9 is increased in blood, sputum and BALF from
COPD patients [61,62]. Additionally, was found a reduction in positive cells to MMP-9 induced by
monoterpenes treatment in PPE animals. The activity of MMP-9 is controlled by TIMP-1 [63] and
although in this study the monoterpenes reduced MMP-9, this treatment did not affect TIMP-1 positive
cells. These findings suggest that monoterpenes contribute to the balance between MMP-9 and TIMP-1
since it reduced the MMP-9 but maintained the levels of TIMP-1 in lung, avoiding the tissue destruction
and consequently remodeling. Although other authors have shown the remodeling process in PPE
models, few studies have evaluated the effects of monoterpenes in this process.
The NF-κB is a signaling pathway that positive regulates pro-inflammatory cytokines in lung
diseases [64,65]. Monoterpenes thymol, carvacrol and p-cymene reduced the positive cells to NF-κB in
lung and it justified the effects of these compounds in reducing inflammation. In COPD, the NF-κB
activation could occur in response to increase levels of IL-1β [66] and the reduction of IL-1β observed
by monoterpenes treatment could justified the effects in NF-κB.
The NF-κB pathway is regulated by redox system and could be influenced by an unbalance
between oxidant and anti-oxidants enzymes [67]. The isoprostane 8-PGF-2α is a product formed in
the lipid peroxidation and could be used as an indirect marker of oxidative stress, being elevated in
COPD patients [68,69] and in emphysema models [18,70,71]. Interestingly, only thymol reduced the
exhaled nitric oxide, which has been used as a marker to both detect the levels of lung inflammation
and oxidative stress [72]. A possible explanation could be related to the contribution from constitutive
isoforms in ENO, which could be modified for one compound or the other. However these finding
should be detailed investigated in the future.
The monoterpenes p-cymene, carvacrol and thymol are bioactive molecules with
anti-inflammatory potential [73], which could be associated to anti-oxidant activity. In this case,
thymol and carvacrol displayed higher potential in comparison to p-cymene since these are phenolic
compounds and showed one hydroxyl group bearing to benzene ring, which could be associated
to the capacity of established free radicals preventing the lipid peroxidation [26,27]. Interestingly
in this study was observed an isoprostane reduction in lung tissue after treatment with these three
related compounds suggesting that the structural differences (presence of absence of hydroxyl group
in the molecular structure) do not interfere significantly in biological effects in this model. This could
be partially explained by metabolization of p-cymene in vivo affording active carvacrol and other
oxygenated derivatives [74]. Previous studies have reports the effects of carvacrol in a model of COPD
and showed that the increase in thiol group in COPD animals is the main mechanism involved in the
benefic effects of carvacrol [57].
It is also important to consider that the effects of thymol and carvacrol could occur in the elastase
activity, an enzyme that displayed an important role in the development of emphysema [75–77]. Even
considering that the effects of these compounds are in the elastase activity, the clinical interest is
relevant since the direct action of a drug in the activity of elastase could be benefic to COPD patients
since this enzyme is involved in the progression and development of the disease.
In conclusion, the results of the present study indicate a preventive effect of monoterpenes on
lung emphysema by controlling the inflammation, avoiding the lung remodeling through NF-κB
and isoprostane reduction (Figure 6). These findings could be of great clinical interest suggesting a
potential role of monoterpenes on lung inflammation and oxidative stress in COPD.
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Figure 6. Monoterpenes probably mechanism is related to reduction in inflammation, oxidative stress
and in NF-κB in lung of PPE-instilated animals. (A) The PPE instillation induces inflammation and
increase marker of oxidative stress. Cytokines such as IL-6, KC, IL-1β and IL-17 are released and
induce the perpetuation of inflammation. Together with oxidative stress, there is activation in NF-κB
pathway, which in turn up-regulated transcription of proinflammatory cytokines and iNOS, that can
induce an increase in exhaled nitric oxide. Augment in MMP-9 positive cells can amplify inflammation
and contribute to the destruction of lung tissue culminating with collagen fibers deposition; (B) The
administration of monoterpenes led to a reduction of the inflammatory process and consequent
reduction in oxidative stress, which is related to the effects of monoterpenes in cytokines reduction
(IL-6, KC, IL-1b and IL-17), NF-κB and isoprostane. These anti-inflammatory and antioxidant effects
contributed to reduction in tissue destruction.
4. Materials and Methods
4.1. General Experimental Procedures
13C-NMR spectra were recorded 75 MHz in an Ultrashield 300 Advance III spectrometer
(Bruker, Fremont, CA, USA) using CDCl3 (Tedia Brazil, Rio de Janeiro, Brazil) as solvent and
TMS (Aldrich, St. Louis, MO, USA) as internal standard. Silica gel for flash chromatography
(Merck, Kenilworth, NJ, USA, 230–400 mesh) and silica gel 60 F254 (Merck, Kenilworth, NJ, USA)
were used for column chromatography and for analytical (0.25 mm) TLC, respectively. GC-FID
chromatograms were obtained on a GC-2010 gas chromatograph (Shimadzu, Kyoto, Japan) equipped
with an flame ionization detector (FID) and one automatic injector AOC-20i (Shimadzu, Kyoto, Japan)
using RtX-5 capillary column (5% phenyl, 95% polydimethylsiloxane (Restek, Bellefonte, PA, USA,
30 m × 0.32 mm × 0.25 µm film thickness). These analyses were performed by injecting 1.0 µL of a
1.0 mg/mL solution of sample material in pentane in a split mode (1:10) employing helium as the
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carrier gas (1 mL/min) under the following conditions: injector and detector temperatures of 250 ◦C
and 280 ◦C, respectively; oven programmed temperature from 100–260 ◦C at 5 ◦C/min, holding 15 min
at 260 ◦C. LREIMS analysis was carried out using a MS-QP-5050A mass spectrometer (Shimadzu,
Kyoto, Japan), operating under an ionization voltage of 70 eV and an ion source temperature of 230 ◦C.
4.2. Chemical and Reagents
All solvents used were of analytical grade and purchased from CAAL (São Paulo, Brazil) while
elastase was obtained from Sigma (St. Louis, MO, USA, 6.6 units/mg, E1250, type I). ELISA and
antibodies were purchased from R&D Systems (Minneapolis, MN, USA).
4.3. Plant Material
L. sidoides was collected in the Atlantic Forest Biome in São Paulo State, Brazil, in March, 2014.
The studied species was identified by Prof. Euder G.A. Martins and its identification of was possible
comparing the voucher specimens with those deposited in the Herbarium of the Universidade de
São Paulo—SP.
4.4. Essential Oil Extraction
Fresh leaves (200 g) were subjected to hydrodistillation in a Clevenger type apparatus for 4 h.
After extraction using CH2Cl2 the essential oil was dried using anhydrous Na2SO4, filtered and the
solvent was evaporated under reduced pressure to afford 644 mg of crude essential oil (yield 0.32%).
4.5. Isolation of Monoterpenes
Part of the crude essential oil of L. sidoides (400 mg) was subjected to separation over flash
silica gel column chromatography eluted with CH2Cl2 and CH2Cl2:MeOH (99:1, 98:2 and 95:5).
Using this procedure, were obtained 45 fractions (5 mL each) which were analyzed by GC-FID and
then pooled into eight groups (A–H). Group B (12 mg) was composed by pure p-cymene (98.5%)
whereas groups D (16 mg) and G (66 mg) were composed by carvacrol (purity 99.0%) and thymol
(purity 99.6%), respectively.
4.5.1. p-Cymene
Colorless oil. 13C-NMR (75 MHz, CDCl3) δC: 135.1 (C-1), 126.3 (C-2/C-6), 129.0 (C-3/C-5), 33.8
(C-7), 24.1 (C-8/C-9), 20.9 (C-10). LREIMS m/z (rel. int.): 134 (25), 119 (100), 103, 91 (28), 77, 65 (11).
4.5.2. Carvacrol
Amorphous solid. 13C-NMR (75 MHz, CDCl3) δC: 130.8 (C-1), 153.6 (C-2), 121.0 (C-3), 148.4 (C-4),
118.7 (C-5), 112.9 (C-6), 33.6 (C-7), 23.9 (C-8/C-9), 15.3 (C-10). LREIMS m/z (rel. int.): 150 (28), 135 (100),
115, 107 (16), 91 (20), 77 (14).
4.5.3. Thymol
Amorphous solid. 13C-NMR (75 MHz, CDCl3) δC: 131.3 (C-1), 126.2 (C-2), 152.5 (C-3), 136.5 (C-4),
121.6 (C-5), 116.0 (C-6), 26.6 (C-7), 22.6 (C-8/C-9), 20.8 (C-10). LREIMS m/z (rel. int.): 150 (27), 135 (100),
115 (18), 107 (15), 91 (24), 77 (12).
4.6. Animals
Male C57BL/6 (6–8 weeks) mice received humane care according to the “Guide for the Care and
Use of Laboratory Animals” (Institute of Laboratory Animal Resources-1996, Washington, DC, USA).
All surgical procedures were performed while the animals were under general anesthesia. The male
mice used in the present study were maintained in a temperature-controlled room at 21–23 ◦C with a
12-h light/dark cycle and ad libitum access to water and food. This study was approved by the Ethics
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Committees of Federal University of São Paulo (São Paulo, Brazil, protocol number 715701/15) and of
University of São Paulo (protocol number 029/15).
4.7. Experimental Design
Forty male C57BL6J mice were aleatory distributed among five experimental groups: A, SAL +
VE group: animals that received nasal instillation of saline + vehicle treatment (50% DMSO + 50%
Saline); B, PPE + VE group: animals that received nasal instillation of porcine pancreatic elastase
(PPE) + vehicle (50% DMSO + 50% Saline) treatment; C, PPE + TM group: animals that received nasal
instillation of elastase + thymol treatment; D, PPE + CV group: animals that received nasal instillation
of elastase plus carvacrol treatment; and E, PPE + pC group: animals that received nasal instillation of
elastase and p-cymene treatment. DMSO was used to dissolve the tested monoterpenes.
4.8. PPE-Induced Emphysema in Mice
Mice were anesthetized with xylazine (40 mg/kg) and ketamin (5 mg/kg) and intranasal instilled
with 50 µL of PPE (6.6 units/mg, E1250, type I, Sigma-Aldrich) [78] with a concentration of de 0.677 UI
(day zero). Control group received an intranasal instillation of the same volume of saline. All animals
were evaluated 28 days after the intranasal instillation.
4.9. Monoterpenes Treatment
Ten microliters of p-cymene, carvacrol, thymol or vehicle was administered by intranasal
instillation 30 min after PPE or saline instillation, and then repeated on 7th, 14th, 21st, and 28th
days of the protocol [18]. The dose of p-cymene, carvacrol, thymol used were 20 mg/kg chosen based
in previous studies of our lab in acute lung injury models (unpublished results) diluted in DMSO and
saline in 1:1 proportion. Previous studies determined that this vehicle was not toxic for animals [18,79].
4.10. Exhaled Nitric Oxide and BALF Collection
Animals were anesthetized with injection of thiopental (70 mg/kg), tracheostomized and
connected to a ventilator for small animals (Harvard 683; Harvard Apparatus, South Natick, MA,
USA) to collect the exhaled nitric oxide (ENO). The concentrations of ENO were measured by
chemiluminescence using a fast-responding analyzer (NOA 280; Sievers Instruments, Boulder, CO,
USA), as previously described [19]. We measured ENO levels at the expiratory port of the ventilator
using a Mylar bag during 10 min. A NO filter was attached to the breathing circuit in order to avoid
environment contamination. After NO collection, animals were exsanguinated, and the BALF was
collected by washing the lungs with 0.5 mL of sterile saline and withdrawing the fluid (3 times).
For total and differential cell counting, the BALF was centrifuged (Model GS-6R Centrifuge, Beckman
Instruments, Fullerton, CA, USA) at 800 g for 8 min at 5 ◦C, and the cell pellet was resuspended in
0.2 mL of sterile saline. The total viable cell count was determined using a Neubauer haemocytometer
chamber (Carl Roth, Karlsruhe, Germany), and differential cells (at least 300 cells) were counted
using an optical microscope (Model BX40 Olympus Optical Co, Tokyo, Japan) after the cytocentrifuge
preparations of the BALF (450 rpm for 6 min) (model: Cytospin 3, Shandon Instruments, Sewickley,
PA, USA) and Diff-Quick staining (Biochemical Sciences Inc., Swedesboro, NJ, USA) [18].
The protein concentrations of IL-6, IL-8, IL-1β and IL-17 in the BALF were assayed by ELISA
according to the manufacturer’s protocol for a Duo-Set kit from R&D Research and Development
(San Diego, CA, USA) [18] and were expressed in pg of cytokine/mL BALF.
4.11. Lung Histopathology and Immunohistochemistry
Lungs were removed in bloc, the right lung was fixed, and histological sections (3 µm thickness)
were stained with hematoxylin and eosin (H&E) to evaluate the mean linear intercepts, an index that
is widely used to characterize the presence of emphysema [21] or picro-sirius (Direct Red 80, CI 35780;
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Sigma-Aldrich) to identify collagen fibers [18]. With a 50-line, 100-point grid connected to the ocular of
the microscope (Model BX40 Olympus Co.), was assessed the Mean Linear Intercepts (Lm) and the
volume proportion of collagen fibers in the alveolar tissue using a point-counting technique. The mean
linear intercept (Lm) was determined at a magnification of 200× in 20 non-overlapping fields of the
distal lung parenchyma per animal, and the number of times that the lines of the integrating eyepiece
intersected with the alveolar septum was counted. The volume proportion of collagen was determined
in 10 lung fields of each animal by dividing the number of points corresponding to collagen by the
total number of points corresponding to alveolar septa (400×).
Immunohistochemistry was performed using anti-MMP-9 (goat polyclonal IgG diluted to
1:500), anti-TIMP-1 (rabbit polyclonal IgG diluted to 1:100), anti-NF-κB p65 (rabbit polyclonal
igG diluted to 1:300) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and the
biotin–streptavidin–peroxidase method. We used the Vectastain ABC Kit (Vector Elite PK-6105,
Burlingame, CA, USA) and DAB (Sigma-Aldrich) to reveal the staining. We determined the number of
cells that were positive for MMP-9, TIMP-1 and NF-κB using the point-counting technique as described
above. The number of points corresponding to alveolar septa and the number of positive cells within
the alveolar septa were counted, and the results were expressed as cells per unit area (104 µm2) [18].
4.12. Statistical Analyses
The results were statistically analyzed using the SigmaStat (Jandel Scientific, San Rafael, CA, USA)
and analysis of variance ANOVA factor was used. The data were obtained and therefore parametric test
was used for post hoc Student-Newman-Keuls test. A p < 0.05 was considered statistically significant.
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